US pharmaceuticals giant Johnson & Johnson on Thursday announced it was buying Swiss medical firm Actelion for $30 billion (27.9 billion euros). Johnson & Johnson's CEO and chairman Alex Gorsky said in a statement that the acquisition of Actelion, a leader in medicines treating high blood pressure, offered "compelling value" to shareholders in both companies. |
GMT 14:12 2018 Tuesday ,23 January
Oscar best director nomineesGMT 14:09 2018 Tuesday ,23 January
Oscar best actress nomineesGMT 14:06 2018 Tuesday ,23 January
Oscar best actor nomineesGMT 13:58 2018 Tuesday ,23 January
Oscar best foreign film nomineesGMT 20:03 2018 Monday ,22 January
Eurozone approves 6.7-bln-euro bailout tranche for GreeceGMT 20:00 2018 Monday ,22 January
Trump to travel to Davos as shutdown deal reached: W.HouseGMT 19:57 2018 Monday ,22 January
Democrats to vote to reopen US government: SchumerGMT 19:53 2018 Monday ,22 January
Afrin clashes kill 54 Syrian Kurd and pro-Turkey fighters: monitorMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor